Familial paroxysmal nonkinesigenic dyskinesia: Clinical and genetic analysis of a Taiwanese family

Tu Hsueh Yeh, Juei Jueng Lin, Szu Chia Lai, Yah Huei Wu-Chou, An Chih Chen, Kuo Chu Yueh, Rou Shayn Chen, Chin Song Lu

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Paroxysmal nonkinesigenic dyskinesia (PNKD) is a rare disorder in autosomal dominant inheritance. The clinical features and genetic findings of PNKD, rarely described in the Asians, were mostly delineated from European families. The present study characterized the clinical and genetic findings of a Taiwanese PNKD family. The clinical features of our five patients in successive three generations included onset age less than 10 years, attack duration between 3 min and 4 h, and a variety of aura symptoms. The attacks were provoked not by sudden action but by emotional stress, caffeine, fatigue, heavy exercise and sleep deprivation. Sleep could abolish or diminish the attack and the attacks responded well to clonazepam. Sequencing the whole coding region of PNKD/MR-1 gene identified a heterozygous c.20C>T (p.Ala7Val) mutation which was clearly segregated in the five affected patients. Comparing our patients with previously reported 18 families with PNKD/MR-1 mutations, the majority of the patients exhibited quite similar manifestations in attack patterns and precipitating factors. The recurrent conservative mutations in different ethnicities indicate importance in the pathogenesis of PNKD.

Original languageEnglish
Pages (from-to)80-84
Number of pages5
JournalJournal of the Neurological Sciences
Volume323
Issue number1-2
DOIs
Publication statusPublished - Dec 15 2012
Externally publishedYes

Fingerprint

Mutation
Clonazepam
Precipitating Factors
Sleep Deprivation
Caffeine
Age of Onset
Psychological Stress
Fatigue
Paroxysmal nonkinesigenic dyskinesia
Epilepsy
Sleep
Exercise
Genes
Clinical Studies

Keywords

  • Autosomal dominant
  • Benzodiazepines
  • Genotype-phenotype correlation
  • Myofibrillogenesis regulator 1 (MR-1) gene
  • Paroxysmal dyskinesia
  • Paroxysmal nonkinesigenic dyskinesia (PNKD)

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Familial paroxysmal nonkinesigenic dyskinesia : Clinical and genetic analysis of a Taiwanese family. / Yeh, Tu Hsueh; Lin, Juei Jueng; Lai, Szu Chia; Wu-Chou, Yah Huei; Chen, An Chih; Yueh, Kuo Chu; Chen, Rou Shayn; Lu, Chin Song.

In: Journal of the Neurological Sciences, Vol. 323, No. 1-2, 15.12.2012, p. 80-84.

Research output: Contribution to journalArticle

Yeh, Tu Hsueh ; Lin, Juei Jueng ; Lai, Szu Chia ; Wu-Chou, Yah Huei ; Chen, An Chih ; Yueh, Kuo Chu ; Chen, Rou Shayn ; Lu, Chin Song. / Familial paroxysmal nonkinesigenic dyskinesia : Clinical and genetic analysis of a Taiwanese family. In: Journal of the Neurological Sciences. 2012 ; Vol. 323, No. 1-2. pp. 80-84.
@article{2f120558a863417a8682eb68110fcaa9,
title = "Familial paroxysmal nonkinesigenic dyskinesia: Clinical and genetic analysis of a Taiwanese family",
abstract = "Paroxysmal nonkinesigenic dyskinesia (PNKD) is a rare disorder in autosomal dominant inheritance. The clinical features and genetic findings of PNKD, rarely described in the Asians, were mostly delineated from European families. The present study characterized the clinical and genetic findings of a Taiwanese PNKD family. The clinical features of our five patients in successive three generations included onset age less than 10 years, attack duration between 3 min and 4 h, and a variety of aura symptoms. The attacks were provoked not by sudden action but by emotional stress, caffeine, fatigue, heavy exercise and sleep deprivation. Sleep could abolish or diminish the attack and the attacks responded well to clonazepam. Sequencing the whole coding region of PNKD/MR-1 gene identified a heterozygous c.20C>T (p.Ala7Val) mutation which was clearly segregated in the five affected patients. Comparing our patients with previously reported 18 families with PNKD/MR-1 mutations, the majority of the patients exhibited quite similar manifestations in attack patterns and precipitating factors. The recurrent conservative mutations in different ethnicities indicate importance in the pathogenesis of PNKD.",
keywords = "Autosomal dominant, Benzodiazepines, Genotype-phenotype correlation, Myofibrillogenesis regulator 1 (MR-1) gene, Paroxysmal dyskinesia, Paroxysmal nonkinesigenic dyskinesia (PNKD)",
author = "Yeh, {Tu Hsueh} and Lin, {Juei Jueng} and Lai, {Szu Chia} and Wu-Chou, {Yah Huei} and Chen, {An Chih} and Yueh, {Kuo Chu} and Chen, {Rou Shayn} and Lu, {Chin Song}",
year = "2012",
month = "12",
day = "15",
doi = "10.1016/j.jns.2012.08.015",
language = "English",
volume = "323",
pages = "80--84",
journal = "Journal of the Neurological Sciences",
issn = "0022-510X",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Familial paroxysmal nonkinesigenic dyskinesia

T2 - Clinical and genetic analysis of a Taiwanese family

AU - Yeh, Tu Hsueh

AU - Lin, Juei Jueng

AU - Lai, Szu Chia

AU - Wu-Chou, Yah Huei

AU - Chen, An Chih

AU - Yueh, Kuo Chu

AU - Chen, Rou Shayn

AU - Lu, Chin Song

PY - 2012/12/15

Y1 - 2012/12/15

N2 - Paroxysmal nonkinesigenic dyskinesia (PNKD) is a rare disorder in autosomal dominant inheritance. The clinical features and genetic findings of PNKD, rarely described in the Asians, were mostly delineated from European families. The present study characterized the clinical and genetic findings of a Taiwanese PNKD family. The clinical features of our five patients in successive three generations included onset age less than 10 years, attack duration between 3 min and 4 h, and a variety of aura symptoms. The attacks were provoked not by sudden action but by emotional stress, caffeine, fatigue, heavy exercise and sleep deprivation. Sleep could abolish or diminish the attack and the attacks responded well to clonazepam. Sequencing the whole coding region of PNKD/MR-1 gene identified a heterozygous c.20C>T (p.Ala7Val) mutation which was clearly segregated in the five affected patients. Comparing our patients with previously reported 18 families with PNKD/MR-1 mutations, the majority of the patients exhibited quite similar manifestations in attack patterns and precipitating factors. The recurrent conservative mutations in different ethnicities indicate importance in the pathogenesis of PNKD.

AB - Paroxysmal nonkinesigenic dyskinesia (PNKD) is a rare disorder in autosomal dominant inheritance. The clinical features and genetic findings of PNKD, rarely described in the Asians, were mostly delineated from European families. The present study characterized the clinical and genetic findings of a Taiwanese PNKD family. The clinical features of our five patients in successive three generations included onset age less than 10 years, attack duration between 3 min and 4 h, and a variety of aura symptoms. The attacks were provoked not by sudden action but by emotional stress, caffeine, fatigue, heavy exercise and sleep deprivation. Sleep could abolish or diminish the attack and the attacks responded well to clonazepam. Sequencing the whole coding region of PNKD/MR-1 gene identified a heterozygous c.20C>T (p.Ala7Val) mutation which was clearly segregated in the five affected patients. Comparing our patients with previously reported 18 families with PNKD/MR-1 mutations, the majority of the patients exhibited quite similar manifestations in attack patterns and precipitating factors. The recurrent conservative mutations in different ethnicities indicate importance in the pathogenesis of PNKD.

KW - Autosomal dominant

KW - Benzodiazepines

KW - Genotype-phenotype correlation

KW - Myofibrillogenesis regulator 1 (MR-1) gene

KW - Paroxysmal dyskinesia

KW - Paroxysmal nonkinesigenic dyskinesia (PNKD)

UR - http://www.scopus.com/inward/record.url?scp=84867885878&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867885878&partnerID=8YFLogxK

U2 - 10.1016/j.jns.2012.08.015

DO - 10.1016/j.jns.2012.08.015

M3 - Article

C2 - 22967746

AN - SCOPUS:84867885878

VL - 323

SP - 80

EP - 84

JO - Journal of the Neurological Sciences

JF - Journal of the Neurological Sciences

SN - 0022-510X

IS - 1-2

ER -